Jump to:

Efexor XL licence extended

20 December 2007, 10:50am

Efexor XL (venlafaxine) is now indicated in moderate to severe generalised social anxiety disorder/social phobia in adults.

Efexor is also indicated in major depressive disorder and in moderate to severe generalised anxiety disorder. The recommended dose in social anxiety disorder is 75mg once daily.

If the patient has failed to respond after 12 weeks, alternative therapy should be considered. Continuation of treatment in a responding patient can be considered on an individual basis, but there is no evidence of efficacy beyond six months.

 

Further information: Wyeth 0845 3670098

You must log in to make full use of all the site content and features.

New users can register here free for full site access.

 

MIMS Specialist Journals

Now available on www.mims.co.uk

Click here to view

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

NICE Guidance: IBS

NICE Guidance: IBS

MIMS Summary of
NICE guideline

NICE Guidance: Lipid Modification

NICE Guidance: Lipid Modification

MIMS Summary of
NICE guideline

Quick-reference table: antibiotics

Quick-reference table: antibiotics

Treatment regimens for common infections

Referral Guidelines for Breast Disorders

Referral Guidelines for Breast Disorders

MIMS Summary of NHS Cancer Screening Referral Guidelines

Back to top